jumpger.blogg.se

Rossi said this eliminates the need for patients to carry their immobilization devices to another location, or to compete with other departments in the health system for access to this technology.ĭr.

Scripps Proton Therapy Center offers advanced technology needed for accurate tumor targeting, including CT and PET-CT scanners and an MRI machine. Scripps also plans to be involved in prospective randomized research trials comparing proton and X-ray radiation therapy through its involvement with NRG Oncology, a collaborative research organization of the National Cancer Institute. Currently, Scripps is part of a PCG registry trial to gather clinical outcomes data from all of its patients, regardless of diagnosis, and expects to expand into tumor-specific studies that will explore areas such as hypofractionation. More than one-third of Scripps’ proton patients to date have come from outside San Diego, including nine different states, and as far away as Monaco and China.Īs a member of the Proton Collaborative Group (PCG), Scripps Health is participating in multi-institutional research studies to help optimize proton therapy. Treatment at Scripps Proton Therapy Center is available to any health system in San Diego and beyond. Rossi said the center has received patients both from within the Scripps Health system and through its affiliate providers, Rady Children’s Hospital-San Diego and UC San Diego Health System. Rossi also noted that the new center is offering remarkably accurate radiation delivery and the ability to treat larger tumor fields than previously possible, while also providing greater efficiency with on-time patient treatments.ĭr. Rossi said physicians at the Scripps Proton Therapy Center have treated a breadth of tumor sites in the center’s first 15 months that previous new proton centers have taken two years or more to accomplish.

Conference attendees will tour Scripps Proton Therapy Center as part of the annual meeting’s proceedings.ĭr.

Presentations and discussions at the conference will focus on the latest technological advances and clinical applications in particle beam therapy for cancer patients. The nation’s first and only proton therapy center to treat patients exclusively with pencil-beam scanning is reporting exceptional results in delivering cancer treatment since opening for patient care just more than a year ago.Ĭarl Rossi, MD, medical director of the Scripps Proton Therapy Center in San Diego, offered the assessment at the 54th annual Particle Therapy Co-Operative Group (PTCOG) Conference, which is being held in San Diego May 18 through May 23.